@article{gallois:hal-03283091,
TITLE = {Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial},
AUTHOR = {Gallois, Claire and Emile, Jean-Fran{\c c}ois and Kim, Stefano and Monterymard, Carole and Gilabert, Marine and Bez, J{\'e}r{\'e}mie and Li{\`e}vre, Astrid and Dahan, Laetitia and Laurent-Puig, Pierre and Mineur, Laurent and Coriat, Romain and Legoux, Jean-Louis and Hautefeuille, Vincent and Phelip, Jean-Marc and Lecomte, Thierry and Sokol, Harry and Capron, Claude and Randrian, Violaine and Lepage, Come and Lomenie, Nicolas and Kurtz, Camille and Taieb, Julien and Tougeron, David},
URL = {https://hal.science/hal-03283091},
JOURNAL = {Digestive and Liver Disease},
PUBLISHER = {Elsevier},
VOLUME = {53},
NUMBER = {10},
PAGES = {1254-1259},
YEAR = {2021},
MONTH = Jun, DOI = {10.1016/j.dld.2021.06.009},
KEYWORDS = {Checkpoint blockade ; Clinical trial ; Colorectal cancer ; Tumour-infiltrating lymphocytes},
PDF = {https://hal.science/hal-03283091/file/Gallois%20et%20al%20-%202021-%20Pembrolizumab%20with%20Capox%20Bevacizumab%20in%20patients%20with%20microsatellite%20stable%20metastatic%20colorectal%20cancer.pdf},
HAL_ID = {hal-03283091},
HAL_VERSION = {v1},
}